ATG9B Antikörper (AA 110-121)

Produktnummer ABIN5066209

Produktdetails anti-ATG9B Antikörper

Target: ATG9B (Autophagy Related 9B (ATG9B))

Bindungsspezifität: AA 110-121

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ATG9B Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunocytochemistry (ICC), Immunofluorescence (IF)

Spezifität: Highly expressed in placenta (trophoblast cells) and pituitary gland. Not expressed in vascular endothelial.,Detects ~100 kDa.

Kreuzreaktivität: Human, Maus

Aufreinigung: Peptide Affinity Purified

Immunogen: Synthetic peptide from the N-terminal of Human ATG9B (aa. 110-121)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

• WB (1:1000)
• ICC/IF (1:100)
• optimal dilutions for assays should be determined by the user.

Kommentare:

A 1:1000 dilution of ABIN5066209 was sufficient for detection of ATG9B in 15 μg of Human HeLa Cell Lysates by ECL immunoblot analysis using goat anti-rabbit IgG:HRP as the secondary antibody.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: PBS, 50 % glycerol, 0.09 % sodium azide, Storage buffer may change when conjugated

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: -20°C

Details zu ATG9B

Target: ATG9B (Autophagy Related 9B (ATG9B))

Andere Bezeichnung: ATG9B (ATG9B Produkte)

Hintergrund: ATG9B is involved in autophagy and cytoplasm to vacuole transport (Cvt) vesicle formation. Plays a key role in the organization of the preautophagosomal structure/phagophore assembly site (PAS), the nucleating site for formation of the sequestering vesicle. Highly expressed in the placenta and the pituitary gland.

Gen-ID: 285973

NCBI Accession: NP_001303985

UniProt: Q674R7